BridgeBio Pharma Statistics
NASDAQ: BBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
66.50-0.46 (-0.69%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BridgeBio Pharma by the numbers
BridgeBio Pharma has a market capitalization of $13.00 billion based on 195.49M shares outstanding. With trailing EPS of $-3.56, BridgeBio Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.1% below its 50-day average and 9.5% below its 200-day average.
Average daily trading volume is 2.75M shares, or about $182.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BBIO valuation vs. peer median
| Metric | BBIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $13.00B | $12.10B | +7% |
| Avg. volume | 2.75M | 1.65M | +66% |
Peer median across 8 companies: CORT, SMMT, MDGL, JAZZ, ELAN, ASND, BMRN, RDY.
Valuation
- Market cap
- $13.00B
- Price / sales (latest FY)
- 25.89
- EPS (TTM)
- $-3.56
- Shares outstanding
- 195.49M
Price and trading
- Previous close
- 66.96
- Open
- 66.78
- Day range
- 66.15 – 67.57
- 52-week range
- 52.75 – 93.42
- 52-week change
- +22.65%
- Beta
- —
- Volume
- 2.06M
- Average volume
- 2.75M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 13.00B
- Forward Pe
- 2,420.82
- Eps
- -3.56
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 93.42
- Week52 Low
- 52.75
- Avg Volume
- 2.75M
- Shares Outstanding
- 195.49M
- Ma50
- 75.62
- Ma200
- 73.50
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -28.81%
- Pct From52w Low
- 26.07%